Publication | Closed Access

Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly?

Translational MedicineThem ProperlyMedicineDiagnostic TestImmunologyPathologyInnovative DiagnosticsOmicsBiomarker DiscoveryMolecular DiagnosticsLaboratory MedicineHigh-throughput Screening